Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
100 SEK | +1.01% | 0.00% | +27.23% |
May. 08 | Transcript : Devyser Diagnostics AB, Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | Devyser Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 250M 23.03M | Sales 2025 * | 342M 31.55M | Capitalization | 1.61B 149M |
---|---|---|---|---|---|
Net income 2024 * | -3M -277K | Net income 2025 * | 37M 3.41M | EV / Sales 2024 * | 5.61 x |
Net cash position 2024 * | 211M 19.45M | Net cash position 2025 * | 187M 17.22M | EV / Sales 2025 * | 4.16 x |
P/E ratio 2024 * |
-430
x | P/E ratio 2025 * |
41
x | Employees | 118 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 51.4% |
Latest transcript on Devyser Diagnostics AB
1 day | +5.77% | ||
1 week | -0.40% | ||
Current month | +0.20% | ||
1 month | -4.81% | ||
3 months | +18.42% | ||
6 months | +65.55% | ||
Current year | +25.95% |
Managers | Title | Age | Since |
---|---|---|---|
Ulf Axel Klangby
FOU | Founder | 55 | 03-12-31 |
Fredrik Alpsten
CEO | Chief Executive Officer | 58 | - |
Sabina Berlin
DFI | Director of Finance/CFO | 41 | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 20-12-31 | |
Director/Board Member | 52 | 21-12-31 | |
Chairman | 55 | 09-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 100 | +1.01% | 18 282 |
24-05-08 | 99 | +5.77% | 52,152 |
24-05-07 | 93.6 | -0.43% | 15,088 |
24-05-06 | 94 | -6.00% | 34,007 |
24-05-03 | 100 | +0.60% | 1,880 |
Delayed Quote Nasdaq Stockholm, May 08, 2024 at 06:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.95% | 148M | |
+23.37% | 47.02B | |
+48.83% | 41.86B | |
-0.94% | 41.76B | |
-5.86% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- DVYSR Stock